Aileron Scores Series C

Aileron Therapeutics, a Cambridge, Mass.-based developer of cell-permeable peptide technology to help treat cancer and other diseases, has raised $7 million in Series C funding. Backers include Apple Tree Partners and the Novartis Venture Fund. www.aileronrx.com